Cells under microscope

Corporate, Portfolio & Brand Strategy

For 25 years, our global team of senior experts has helped Life Science firms anticipate trends and break through strategic barriers. CRA’s fit-for-purpose approach go beyond a single project, to build a true strategic partnership, providing cross-functional support across industry stakeholders and geographies. Clients rely on CRA’s institutional knowledge and subject matter expertise to provide an independent perspective to address core business issues, drive change, and align internal stakeholders.

Our focus areas


  • 01
    Establishing real-world testing and treatment patterns for EGFR NSCLC patients
    Oncology-focused biotech was looking to establish real-world testing and treatment patterns among EGFR NSCLC patients in US, EU, Japan, and Greater China...
    View engagement
  • 02
    Modeling the financial implications of innovative gene therapy business models
    Biotech client was looking to evaluate the financial implications of various innovative business models/strategic offerings for its novel gene therapy.
    View engagement
  • 03
    Supporting a Phase III R&D strategy within the anti-infective space
    An emerging pharmaceutical company sought to evaluate Phase III development strategies for an anti-infective drug with potential to treat a range of patient...
    View engagement

Contact a Corporate, Portfolio & Brand Strategy expert.

See all Corporate, Portfolio & Brand Strategy experts

Subscribe to receive our latest Insights.